VICENTE
MOLINA RODRIGUEZ
CATEDRATICOS DE UNIVERSIDAD
![Foto de VICENTE](/img/nophoto.png)
![Foto de Universidad Complutense de Madrid](/img/noimage_org.png)
Universidad Complutense de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (25)
2016
-
Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients
European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 8, pp. 743-753
-
Personality traits in patients with cluster headache: a comparison with migraine patients
Journal of Headache and Pain, Vol. 17, Núm. 1
2014
-
Frontal gamma noise power and cognitive domains in schizophrenia
Psychiatry Research - Neuroimaging, Vol. 221, Núm. 1, pp. 104-113
-
Gamma power and cognition in patients with schizophrenia and their first-degree relatives
Neuropsychobiology, Vol. 69, Núm. 2, pp. 120-128
2013
-
Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year
Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161
-
Spatial distribution and cognitive correlates of gamma noise power in schizophrenia
Psychological Medicine, Vol. 43, Núm. 6, pp. 1175-1185
2012
-
Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 38, Núm. 2, pp. 270-275
2005
-
Dorsolateral prefrontal cortex contribution to abnormalities of the P300 component of the event-related potential in schizophrenia
Psychiatry Research - Neuroimaging, Vol. 140, Núm. 1, pp. 17-26
2004
-
An electrophysiological (ERP) component, the recognition potential, in the assessment of brain semantic networks in patients with schizophrenia
Schizophrenia Research, Vol. 71, Núm. 2-3, pp. 393-404
-
Long-term olanzapine treatment and P300 parameters in Schizophrenia
Neuropsychobiology, Vol. 50, Núm. 2, pp. 182-188
2001
-
Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients
Psychiatry Research, Vol. 101, Núm. 1, pp. 75-81
-
El componente P300 de los potenciales evocados en la valoración de la esquizofrenia: Nuevas evidencias y visiones de futuro
Revista de Neurologia, Vol. 32, Núm. 3, pp. 250-258
-
P300 amplitude as a possible correlate of frontal degeneration in schizophrenia
Schizophrenia Research, Vol. 49, Núm. 1-2, pp. 121-128
1998
-
Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia
Psychiatry Research, Vol. 77, Núm. 1, pp. 21-28
1997
-
Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: An exploratory 99mTc-HMPAO SPET study
Schizophrenia Research, Vol. 25, Núm. 1, pp. 11-20
-
Fronto-striato-thalamic perfusion and clozapine response in treatment- refractory schizophrenic patients. A 99mTc-HMPAO study
Psychiatry Research - Neuroimaging, Vol. 76, Núm. 1, pp. 51-61
-
The Wisconsin Card Sorting Test and the assessment of frontal function: A validation study with event related potentials
Neuropsychologia, Vol. 35, Núm. 4, pp. 399-408
1996
-
Perfusion cerebral regional y respuesta a la clozapina en la esquizofrenia resistente al tratamiento
Revista Espanola de Medicina Nuclear, Vol. 15, Núm. 5, pp. 317-324
-
SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine
American Journal of Psychiatry, Vol. 153, Núm. 10, pp. 1343-1346
1995
-
Cerebral perfusion, electrical activity and effects of serotonergic treatment in obsessive-compulsive disorder: A preliminary study
Neuropsychobiology, Vol. 32, Núm. 3, pp. 139-148